Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients.

Publication ,  Journal Article
Wolfe, C; Greenwald, I; Chen, L
Published in: Emerg Infect Dis
November 2010

Duke Scholars

Published In

Emerg Infect Dis

DOI

EISSN

1080-6059

Publication Date

November 2010

Volume

16

Issue

11

Start / End Page

1809 / 1811

Location

United States

Related Subject Headings

  • Pandemics
  • Oseltamivir
  • Neoplasms
  • Middle Aged
  • Microbiology
  • Male
  • Influenza, Human
  • Influenza A Virus, H1N1 Subtype
  • Immunocompromised Host
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wolfe, C., Greenwald, I., & Chen, L. (2010). Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients. Emerg Infect Dis, 16(11), 1809–1811. https://doi.org/10.3201/eid1611.101053
Wolfe, Cameron, Ian Greenwald, and Luke Chen. “Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients.Emerg Infect Dis 16, no. 11 (November 2010): 1809–11. https://doi.org/10.3201/eid1611.101053.
Wolfe C, Greenwald I, Chen L. Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients. Emerg Infect Dis. 2010 Nov;16(11):1809–11.
Wolfe, Cameron, et al. “Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients.Emerg Infect Dis, vol. 16, no. 11, Nov. 2010, pp. 1809–11. Pubmed, doi:10.3201/eid1611.101053.
Wolfe C, Greenwald I, Chen L. Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients. Emerg Infect Dis. 2010 Nov;16(11):1809–1811.

Published In

Emerg Infect Dis

DOI

EISSN

1080-6059

Publication Date

November 2010

Volume

16

Issue

11

Start / End Page

1809 / 1811

Location

United States

Related Subject Headings

  • Pandemics
  • Oseltamivir
  • Neoplasms
  • Middle Aged
  • Microbiology
  • Male
  • Influenza, Human
  • Influenza A Virus, H1N1 Subtype
  • Immunocompromised Host
  • Humans